thymic-factor--circulating and Leukemia--Lymphocytic--Chronic--B-Cell

thymic-factor--circulating has been researched along with Leukemia--Lymphocytic--Chronic--B-Cell* in 1 studies

Other Studies

1 other study(ies) available for thymic-factor--circulating and Leukemia--Lymphocytic--Chronic--B-Cell

Article	Year
[Thymalin in the combined treatment of patients with chronic lympholeukemia]. Vrachebnoe delo, 1989, Issue:3 Clinico-immunologic indices were studied in patients with the B-variant of chronic lympholeukemia (Stage II) under conditions of inclusion of thymalin in the complex treatment. It was established that use of thymalin in patients with chronic lympholeukemia favoured improvement of the functional activity of lymphoid cells, reduced the time of reaching clinico-hematological remission. Thymalin is indicated in the complex treatment of the above condition. Topics: Adjuvants, Immunologic; Aged; Antibody Formation; Antineoplastic Combined Chemotherapy Protocols; Drug Evaluation; Drug Therapy, Combination; Humans; Immunity, Cellular; Leukemia, Lymphocytic, Chronic, B-Cell; Middle Aged; Thymus Hormones	1989

Article

Year

[Thymalin in the combined treatment of patients with chronic lympholeukemia].

Vrachebnoe delo, 1989, Issue:3

Clinico-immunologic indices were studied in patients with the B-variant of chronic lympholeukemia (Stage II) under conditions of inclusion of thymalin in the complex treatment. It was established that use of thymalin in patients with chronic lympholeukemia favoured improvement of the functional activity of lymphoid cells, reduced the time of reaching clinico-hematological remission. Thymalin is indicated in the complex treatment of the above condition.

Topics: Adjuvants, Immunologic; Aged; Antibody Formation; Antineoplastic Combined Chemotherapy Protocols; Drug Evaluation; Drug Therapy, Combination; Humans; Immunity, Cellular; Leukemia, Lymphocytic, Chronic, B-Cell; Middle Aged; Thymus Hormones

1989